Our management team has an extensive track record and experience in the research, development and delivery of RNA therapeutics, with over 50 years of combined experience in RNA delivery technologies and RNA therapeutics.
Robert W. Overell, Ph.D.
President and Chief Executive OfficerRead Bio
Michael Houston, Ph.D.
Chief Scientific OfficerRead Bio
Gordon Brandt, M.D.
Chief Medical OfficerRead Bio
Mary G. Prieve, Ph.D.
Vice President of BiologyRead Bio
Senior Vice President, FinanceRead Bio